Literature DB >> 17909711

Preoperative biliary drainage for hilar cholangiocarcinoma.

Hiroyuki Maguchi1, Kuniyuki Takahashi, Akio Katanuma, Manabu Osanai, Kazuyuki Nakahara, Shinpei Matuzaki, Takahiro Urata, Hirotoshi Iwano.   

Abstract

Hilar cholangiocarcinomas grow slowly, and metastases occur late in the natural history. Surgical cure and long-term survival have been demonstrated, when resection margins are clear. Preoperative biliary drainage has been proposed as a way to improve liver function before surgery, and to reduce post-surgical complications. Percutaneous transhepatic biliary drainage (PTBD) with multiple drains was previously the preferred method for the preoperative relief of obstructive jaundice. However, the introduction of percutaneous transhepatic portal vein embolization (PTPE) and wider resection has changed preoperative drainage strategies. Drainage is currently performed only for liver lobes that will remain after resection, and for areas of segmental cholangitis. Endoscopic biliary drainage (EBD) is less invasive than PTBD. Among EBD techniques, endoscopic nasobiliary drainage (ENBD) is preferable to endoscopic biliary stenting (EBS), because secondary cholangitis (due to the retrograde flow of duodenal fluid into the biliary tree) does not occur. ENBD needs to be converted to PTBD in patients with segmental cholangitis, those with a prolonged need for drainage, or when the extent of longitudinal tumor extension is not sufficiently well characterized.

Entities:  

Mesh:

Year:  2007        PMID: 17909711     DOI: 10.1007/s00534-006-1192-3

Source DB:  PubMed          Journal:  J Hepatobiliary Pancreat Surg        ISSN: 0944-1166


  29 in total

1.  Preoperative biliary drainage before resection for cholangiocarcinoma (Pro).

Authors:  Y Nimura
Journal:  HPB (Oxford)       Date:  2008       Impact factor: 3.647

Review 2.  Current status of preoperative biliary drainage.

Authors:  Junko Umeda; Takao Itoi
Journal:  J Gastroenterol       Date:  2015-07-03       Impact factor: 7.527

3.  Issues in surgery for hilar cholangiocarcinoma.

Authors:  Sudeep R Shah
Journal:  Indian J Surg       Date:  2011-11-29       Impact factor: 0.656

Review 4.  Perihilar cholangiocarcinoma: a surgeon's viewpoint on current topics.

Authors:  Masato Nagino
Journal:  J Gastroenterol       Date:  2012-07-31       Impact factor: 7.527

5.  Endoscopic diagnosis of extrahepatic bile duct carcinoma: Advances and current limitations.

Authors:  Kiichi Tamada; Jun Ushio; Kentaro Sugano
Journal:  World J Clin Oncol       Date:  2011-05-10

6.  Self-expandable metal stents and trans-stent light delivery: are metal stents and photodynamic therapy compatible?

Authors:  Luo-Wei Wang; Li-Bo Li; Zhao-Shen Li; Yang K Chen; Fred W Hetzel; Zheng Huang
Journal:  Lasers Surg Med       Date:  2008-11       Impact factor: 4.025

7.  Metal stents: a bridge to surgery in hilar cholangiocarcinoma.

Authors:  Dirk J Grünhagen; Declan F J Dunne; Richard P Sturgess; Nick Stern; Stephen Hood; Stephen W Fenwick; Graeme J Poston; Hassan Z Malik
Journal:  HPB (Oxford)       Date:  2012-10-16       Impact factor: 3.647

Review 8.  Should preoperative biliary drainage be routinely performed for obstructive jaundice with resectable tumor?

Authors:  Chu Wang; Yiyao Xu; Xin Lu
Journal:  Hepatobiliary Surg Nutr       Date:  2013-10       Impact factor: 7.293

9.  Role of preoperative biliary drainage of liver remnant prior to extended liver resection for hilar cholangiocarcinoma.

Authors:  Timothy J Kennedy; Adam Yopp; Yilin Qin; Binsheng Zhao; Pingzhen Guo; Fan Liu; Larry H Schwartz; Peter Allen; Michael D'Angelica; Yuman Fong; Ronald P DeMatteo; Leslie H Blumgart; William R Jarnagin
Journal:  HPB (Oxford)       Date:  2009-08       Impact factor: 3.647

10.  Endoscopic and percutaneous preoperative biliary drainage in patients with suspected hilar cholangiocarcinoma.

Authors:  Jaap J Kloek; Niels A van der Gaag; Yalda Aziz; Erik A J Rauws; Otto M van Delden; Johan S Lameris; Olivier R C Busch; Dirk J Gouma; Thomas M van Gulik
Journal:  J Gastrointest Surg       Date:  2009-09-15       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.